C.ANIRUDH JAGANNADH, M.SRAVANI, & DR M.D DHANARAJU. (2013). ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA/GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS. International Journal of Pharma and Bio Sciences, 4(2), 750–754. Retrieved from https://ijpbs.net/index.php/journal/article/view/2225